Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06817863 · ClinicalTrials.gov registry record · Phase 1

A Self-Guided Mobile Intervention for Adults With Binge Eating and Obesity

A Phase 1 study of Binge-Eating Disorder and Binge Eating Disorder Associated With Obesity, sponsored by Drexel University.

Recruiting
Registry status
Phase 1
Development phase
30
Enrollment target
1
Study location

NCT06817863: Recruiting Phase 1 study of Binge-Eating Disorder and Binge Eating Disorder Associated With Obesity, sponsored by Drexel University.

NCT06817863 is a Phase 1 study of Binge-Eating Disorder and Binge Eating Disorder Associated With Obesity that is actively recruiting participants, run by Drexel University. The registered enrollment target is 30 participants, below the 1,143-participant average among 37 other Binge-Eating Disorder trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06817863, a Phase 1 study of Binge-Eating Disorder and Binge Eating Disorder Associated With Obesity, is actively recruiting participants, sponsored by Drexel University.

RECRUITING
Registry status
Phase 1
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The proposed study is an open label, non randomized, waitlist controlled single group feasibility study of the feasibility and usability of a digital intervention (called ChangeBite) to be used by individuals with obesity and comorbid binge eating behavior. The proposed research will include approximately 30 participants. Participants will be recruited for this single group pilot trial using online advertising to attend a virtual screening session. Screened participants willing and eligible to participate, will receive informed consent and formally start ChangeBite. Participants will be instructed to engage with ChangeBite and attend follow up assessments on scheduled video calls. Feasibility and acceptability of implementation will be assessed by collecting data on recruitment, retention, usability and satisfaction. The research team will also collect assessment data from participants on feasibility, and usability. In addition to self report scales, semi-structured interviews will be completed with a trained research team member via video call and will be partially recorded. Assessments will be done at baseline, 12 weeks, and 24 weeks. Participants' app use frequency and duration will be tracked using software analytics. Participants' body weight will be captured weekly using a timestamped picture of their weight as it appears on their scale and Body Mass Index will be calculated with these data points.

Primary Outcome

The frequency of binge eating episodes.

Interventions

  • OTHER Digital

Study Locations (1)

Pennsylvania

  • Drexel University - Philadelphia

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-02
Est. Completion 2025-12
Phase Phase 1
Drexel University

92 total trials

What NCT06817863 shows while recruiting

NCT06817863 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,143-participant average among 37 other Binge-Eating Disorder trials with a reported enrollment target (97% lower).

The record links to 2 conditions, with Binge-Eating Disorder appearing as the primary indexed condition, and to 1 intervention - of which Digital is the first listed.

NCT06817863 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06817863 about?

NCT06817863 is a clinical study titled "A Self-Guided Mobile Intervention for Adults With Binge Eating and Obesity". The proposed study is an open label, non randomized, waitlist controlled single group feasibility study of the feasibility and usability of a digital intervention (called ChangeBite) to be used by individuals with obesity and comorbid binge eating behavior. The proposed research will include approxi...

What is the current status of trial NCT06817863?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2025-02. Estimated completion is 2025-12.

What conditions does trial NCT06817863 study?

This clinical trial studies the following conditions: Binge-Eating Disorder, Binge Eating Disorder Associated With Obesity.

What interventions are being tested in trial NCT06817863?

The interventions under investigation include: Digital (OTHER).

Who is sponsoring clinical trial NCT06817863?

This trial is sponsored by Drexel University, which has 92 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06817863 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Binge-Eating Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06817863's enrollment target sits among peer trials

30 31st of 37 higher than 7 of 37 other Binge-Eating Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Binge-Eating Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT06817863, the US trial registry maintained by the National Library of Medicine. NCT06817863 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.